Veeva Systems (NYSE:VEEV) Updates FY 2025 Earnings Guidance

Veeva Systems (NYSE:VEEV) issued an update on its FY 2025 earnings guidance on Saturday morning. The company provided earnings per share guidance of 6.160-6.160 for the period, compared to the consensus earnings per share estimate of 6.150. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.

Analyst Upgrades and Downgrades

Several analysts have weighed in on VEEV shares. Stifel Nicolaus decreased their price objective on shares of Veeva Systems from $250.00 to $210.00 and set a buy rating on the stock in a research note on Friday, May 31st. Royal Bank of Canada reissued an outperform rating and issued a $250.00 price objective on shares of Veeva Systems in a research note on Wednesday, March 27th. Truist Financial raised their price objective on shares of Veeva Systems from $187.00 to $203.00 and gave the company a hold rating in a research report on Friday, March 1st. The Goldman Sachs Group upped their target price on shares of Veeva Systems from $219.00 to $248.00 and gave the stock a buy rating in a research report on Friday, March 1st. Finally, Piper Sandler lowered their price target on shares of Veeva Systems from $245.00 to $235.00 and set an overweight rating for the company in a report on Friday, May 31st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of $228.25.

Veeva Systems Trading Up 1.0 %

NYSE VEEV opened at $184.98 on Tuesday. Veeva Systems has a 12 month low of $162.72 and a 12 month high of $236.90. The stock has a 50 day moving average of $201.55 and a 200-day moving average of $204.44. The company has a market cap of $29.84 billion, a PE ratio of 54.57, a PEG ratio of 1.81 and a beta of 0.80.

Insider Buying and Selling

In related news, SVP Jonathan Faddis sold 3,598 shares of Veeva Systems stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $207.42, for a total transaction of $746,297.16. Following the completion of the sale, the senior vice president now owns 10,668 shares of the company’s stock, valued at approximately $2,212,756.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Veeva Systems news, CFO Timothy S. Cabral sold 15,000 shares of the business’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $184.33, for a total transaction of $2,764,950.00. Following the sale, the chief financial officer now owns 8,391 shares of the company’s stock, valued at $1,546,713.03. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Jonathan Faddis sold 3,598 shares of the stock in a transaction on Monday, April 15th. The shares were sold at an average price of $207.42, for a total value of $746,297.16. Following the completion of the transaction, the senior vice president now owns 10,668 shares of the company’s stock, valued at $2,212,756.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,989 shares of company stock valued at $4,192,363. 10.50% of the stock is owned by insiders.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.